Dr Reddy’s introduces Zoledronic Acid Injection in US

Pharmaceutical News by Saleem S A  12 mnths ago

Dr Reddy’s Laboratories Limited has successfully launched Zoledronic Acid Injection, used for treating osteoporosis and Paget's disease of bone in the US market following approval from the US health regulator, according to BL report.

The zoledronic acid injection, a therapeutic equivalent generic version of Reclast injection in the US market and the zoledronic acid injection (5mg/100mL) is available in a single use vial for Intravenous Infusion. It is generally indicated for the treatment of osteoporosis.

The Reclast brand had total US sales of about $ 355 million for the 12 months ended February 2013, according to IMS Health, the Hyderabad-based company said in a release.

 

Post your Views on Dr Reddy’s introduces Zoledronic Acid Injection in US